PubMed Health⌕ Search

Biomedical subjects

D L Thompson

Publications and source records attributed to D L Thompson.

At least 163 records · Page 9Linked to original sources

Testosterone effects on gonadotropin response to GNRH: cows and pony mares.

Effects of testosterone propionate (TP) treatment on plasma concentrations of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) before and after an injection of gonadotropin releasing hormone (GnRH) were studied using ovariectomized cows and pony mares. An initial injection of GnRH (1 microgram/kg of body weight) was followed by either TP treatment or control injections for 10 (cows) or 11 (ponies) d. A second GnRH injection was administered 1 d after the last TP or oil injection. Concentrations of LH and FSH were determined in samples of plasma taken before and after each GnRH injection. Control injections did not alter the response to GnRH (area under curve) nor the pre-GnRH concentrations of LH and FSH in ovariectomized cows or ponies. Testosterone treatment increased (P less than .01) the FSH release in response to GnRH in ovariectomized mares by 4.9-fold; there was no effect in cows, even though average daily testosterone concentrations were 59% higher than in pony mares. Testosterone treatment reduced the LH release in response to GnRH by 26% in ovariectomized mares (P less than .05) and by 17% in ovariectomized cows (P approximately equal to .051). These results are consistent with a model that involves ovarian androgens in the regulation of FSH secretion in the estrous cycle of the mare, but do not support such a model in the cow.

Animals↗

Active immunization of prepubertal colts against estrogens: hormonal and testicular responses after puberty.

Prepubertal Quarter horse colts were immunized at 6 mo of age with either estrone-17-oxime-bovine serum albumin (n = 4; treated) or with albumin only (n = 5; controls). All colts received booster injections of the appropriate antigen at 8, 10, 12, 16 and 20 mo of age. Blood samples were drawn every 20 d from 6 to 26 mo of age; body weights were determined monthly. Immunization against estrone-albumin resulted in increased binding of [3H]-estradiol in serum within 40 d that was maintained through 24 mo of age. Antisera from treated colts crossreacted equally well with estrone and estradiol and moderately with other estrogens; androgens, progesterone and glucocorticoids all cross-reacted less than .005%. Body weights were not affected by treatment. Concentrations of testosterone were generally higher (P less than .05) in estrogen-immunized colts compared with controls after immunization. Concentrations of luteinizing hormone were not affected by treatment, whereas concentrations of follicle-stimulating hormone were initially increased (P less than .05) in treated colts after immunization. At castration at 27 mo of age, estrogen-immunized colts had greater (P less than .05) testicular and parenchymal weights and produced more (P approximately equal to .055) spermatozoa per horse than did control colts. Seminal characteristics immediately before castration were not affected by treatment. It appears that estrogens are involved in the regulation of several reproductive traits in the colt. Moreover, active immunization against estrogen in the prepubertal colt may be a useful method of increasing testicular size and sperm production rates in the stallion after puberty.

Animals↗

Ultrasonographic features of the fetal Turner syndrome.

Recently we have examined six phenotypically female fetuses in whom the prenatal diagnosis of Turner syndrome was made. All had ultrasonographic examinations during the second trimester. Four showed a striking posterior cranio-cervical lymphocele (cystic hygroma) having a symmetric, trefoil , septated appearance in the coronal plane, combined with serosal fluid collections and cutaneous edema. Two fetuses were normal. It appears that Turner syndrome may present prenatally with variable findings. Perhaps such findings as cranio-cervical lymphocele (cystic hygroma) can undergo spontaneous remission, resulting in a liveborn baby with webbing of the neck. We have noted separation of the cervical vertebrae adjacent to the mass, which may interfere with growth and result in a short cervical spine. Amniocentesis should be done when a cystic mass centered on the posterior aspect of the head and neck is identified on ultrasonography. The constellation of findings, namely a trilobed septation of a cystic mass in the coronal plane, fluid collections in serosal cavities, and anasarca may be pathognomonic of Turner syndrome.

Adult↗

Spermatogenesis, testicular composition and the concentration of testosterone in the equine testis as influenced by season.

The influence of season on spermatogenesis, testicular composition and the concentration of testosterone in the equine testis was evaluated using testes from 45 stallions. Testes were obtained through a commercial abbatoir during September, December-January, March and July. The weights of the testes, the tunica albuginea and testicular parenchyma and the proportion of the testicular parenchyma occupied by seminiferous tubules or interstitial tissue were similar during each season. How ever, diameter of the seminiferous tubules was greater in July than during other months of the study. In addition, the concentration of testosterone within the testicular parenchyma was twice as great during July as during the fall and winter, and this period of peak testicular testosterone concentrations was associated with spermatozoal production rates, which were 65% greater than those observed in September.

Journal Article↗

Age-related and seasonal variation in the Sertoli cell population, daily sperm production and serum concentrations of follicle-stimulating hormone, luteinizing hormone and testosterone in stallions.

Testes and blood samples were obtained from 201 stallions aged 6 months to 20 years in either December-January (nonbreeding season) or June-July (breeding season) to study the effect of age and season on reproductive parameters. Seasonal differences in the Sertoli cell population of adult (4-20 years old) horses were characterized by a 36% larger number of Sertoli cells in the breeding season than in the nonbreeding season. Seasonal elevation in the Sertoli cell population was associated with an increase in testicular weight and daily sperm production per testis (DSP/testis). Concentrations of luteinizing hormone (LH) and testosterone in serum varied with season. Although follicle-stimulating hormone (FSH) concentrations also tended to be higher in the breeding season, this trend was not statistically significant (P less than 0.08). Sertoli cell numbers averaged over both seasons, like testicular weights, increased with age until 4-5 years of age, but were stabilized thereafter. This age-related difference was also associated with increased concentrations of FSH, LH and testosterone, and with increased DSP/testis. The Sertoli cell population was capable of increasing in the adult horse by fluctuating its size with season. The number of elongated spermatids per Sertoli cell over both seasons increased with age up to 4-5 years of age and was stabilized thereafter. Thus, seasonal and/or age-related differences in DSP/testis were associated with significant elevations in serum concentrations of FSH, LH and testosterone, testicular weights, numbers of elongated spermatids per Sertoli cell and elevation of the Sertoli cell population.

Age Factors↗

Effects of testosterone, dihydrotestosterone and estradiol on gonadotropin release after gonadotropin releasing hormone administration in cyclic mares.

Sixteen intact cyclic mares were treated on the fourth day of estrus and then every other day for a total of six injections with 1) testosterone propionate, 2) dihydrotestosterone (DHT) benzoate, 3) estradiol (E2) benzoate or 4) safflower oil. Mares were given gonadotropin releasing hormone (GnRH) on Day 3 of estrus (pretreatment) and again 24 h after the last steroid or oil injection. Treatment with testosterone propionate resulted in a greater (P less than 0.05) follicle-stimulating hormone (FSH) response to the second injection of GnRH compared with all other treatments. Treatment with DHT benzoate also resulted in greater (P less than 0.05) FSH response to GnRH compared with control and E2 benzoate-treated mares. Testosterone propionate and E2 benzoate administration suppressed (P less than 0.05) the normal diestrous rise in FSH concentrations exhibited by the control and DHT benzoate-treated mares. Steroid treatment did not affect the luteinizing hormone (LH) response to GnRH, although testosterone propionate treatment did suppress concentrations of LH in daily blood samples during Days 3 to 6 of treatment. It is concluded that testosterone's effect on FSH after GnRH treatment observed in this and previous experiments can be attributed to two different properties of the hormone or its metabolites acting simultaneously. That is, testosterone increased the secretion of FSH in response to GnRH as did DHT (an androgenic effect). At the same time, testosterone suppressed FSH concentrations in daily blood samples in a manner identical to that of E2 benzoate (an estrogenic effect).

Animals↗

Separate negative feedback effects of estrogen on the pituitary and the central nervous system in the ovariectomized rhesus monkey.

The site(s) of the negative feedback action of estrogen on gonadotropin secretion were studied in the ovariectomized rhesus monkey by observing the serum LH and FSH responses to intravenous GnRH injections at various times after implantation of Silastic capsules filled with estrogen. Circulating estrogen concentrations produced by the capsules were within the normal midcycle range for this species. Four h after estrogen implantation, no LH or FSH response was seen to the GnRH injection, indicating a suppressive effect of the steroid directly on the pituitary. Twelve and 22 h after estrogen implantation, however, the LH and FSH responses were equal to or larger than control responses. Since preinjection LH and FSH levels were below control values at these times and the pituitary responded to exogenous GnRH, it appears that endogenous GnRH secretion was affected, indicating an inhibitory action of estrogen on the central nervous system. Thus these experiments suggest 2 separate negative feedback actions of estrogen: a transient one directly on the pituitary and a longer lasting effect on the central nervous system.

Animals↗

Oestrogen secretion by in-vitro perfused testes: species comparison and factors affecting short-term secretion.

Testes from mature rats, rabbits, hamsters, guinea-pigs and dogs were perfused in vitro with added gonadotrophins to study the qualitative and quantitative aspects of oestrogen secretion by these species. After separation by high performance liquid chromatography (HPLC), the major oestrogen secreted by the testes of all five species was oestradiol-17 beta; lesser amounts of oestrone were also detected for all species. Secretion rates of oestradiol and testosterone were determined for one testis from each of six animals of each species after purification by HPLC. Oestradiol and testosterone secretion varied (P less than 0.05) among species on both per testis and per gram of testis bases. The rabbit, which was a high secretor of oestradiol, was used in subsequent experiments to study the factors which affect short-term oestradiol secretion by perfused testes. Luteinizing hormone (NIAMDD-LH-S21) at 100 ng/ml significantly stimulated oestradiol secretion by 2.9-fold and increased testosterone secretion by 155-fold. Follicle-stimulating hormone (NIH-FSH-S11) had no significant effect on secretion of either steroid. In a time-course study in which LH stimulation was started after 45 min of control perfusion, the rates of increase in oestradiol and testosterone secretion over time were similar. Increasing amounts of testosterone added directly to the arterial perfusion medium (0-10 micrograms/ml) resulted in an increase in oestradiol secretion in the absence of gonadotrophins. Oestradiol secretion increased in a dose-dependent manner up to 1.0 microgram testosterone/ml; there was no further stimulation of oestradiol secretion at 10 micrograms testosterone/ml. When testes were perfused with saturating concentrations of testosterone (10 micrograms/ml) neither LH nor FSH at 100 ng/ml increased oestradiol secretion above control values. It appears that the major factor affecting oestradiol secretion by in-vitro perfused rabbit testes is the amount of substrate (testosterone) available for aromatization.

Animals↗

Effects of melatonin and thyrotropin releasing hormone on mares during the nonbreeding season.

Two hormonal treatments, chosen for their effectiveness in other seasonally breeding species, were tested in mares during the nonbreeding season to determine if they could induce ovarian activity and estrus during the winter. Of 15 functionally anestrous (anovulatory) mares, five received intravaginal, polyurethane sponges containing .75 g of melatonin on December 16; fresh sponges containing melatonin were inserted weekly until February 3. These mares also received daily injections of saline. Five other mares received daily im injections of 100 micrograms of thyrotropin-releasing hormone (TRH) and control sponges during the treatment period. The remaining five mares were given control injections and control sponges throughout the experiment. Intravaginal sponges containing melatonin increased (P less than .05) concentrations of melatonin in systemic plasma for at least 7 d to levels at least 10-fold higher than those expected during the nighttime hours. The TRH significantly increased concentrations of thyroid-stimulating hormone within 60 min after injection, whereas there was no detectable increase in concentrations of prolactin after TRH. Ovarian size in all three groups of mares was increased (P less than .05) shortly after the onset of the treatment regimens. Moreover, there were surges in concentrations of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in plasma closely associated with sponge insertion and(or) injection of TRH or saline in mares of all groups. Due to the temporal correlation of gonadotropin surges and sponge insertion, we suspect that placement of intravaginal sponges may have caused the release of LH and FSH, perhaps through a neuroendocrine reflex. These surges in gonadotropins may have mediated the ovarian response. Alternatively, ovarian activity may have been stimulated by an unknown environmental factor, a possibility that was not examined in this study. Melatonin or TRH did not augment or inhibit this nonspecific response.

Animals↗

Testosterone effects on mares during synchronization with altrenogest: FSH, LH, estrous duration and pregnancy rate.

Twelve mares fed altrenogest for 14 d were used to study the effects of a single injection of testosterone propionate on concentrations of follicle-stimulating hormone (FSH) during diestrus, and to relate the normal and perturbed patterns of FSH secretion to subsequent estrous characteristics and fertility. Seven of 12 mares received testosterone propionate at 200 micrograms/kg of body weight on d 5 of progestogen feeding. Mares were teased and blood samples were drawn daily; all mares were artificially inseminated at the first estrus after progestogen treatment. Testosterone propionate treatment caused a 50% reduction in concentration of FSH in plasma within 24 h, and this effect persisted through 48 h after injection. Within 4 d after the suppression of FSH secretion, concentrations of FSH rebounded and were significantly elevated compared with control values during the last 4 d of progestogen feeding. Testosterone propionate at this dosage also elicited estrous behavior in five of seven treated mares within 24 h after injection. After withdrawal of progestogen feeding, the interval to onset of estrus, duration of estrus, and magnitude of the luteinizing hormone peak were similar between groups (P greater than .05). Six of seven treated mares and three of five control mares became pregnant to breeding on the first estrus after progestogen treatment. Because manipulation of the normal pattern of FSH secretion during diestrus did not affect estrous characteristics or fertility of the subsequent estrus, such treatment may have potential as a means of synchronizing FSH surges during diestrus in the mare.

Animals↗

Testosterone administration to mares during estrus: duration of estrus and diestrus and concentrations of LH and FSH in plasma.

To study the possible role of ovarian androgens in regulation of follicle stimulating hormone (FSH) secretion in the cycling mare, five mature, intact mares were treated with testosterone (20 micrograms/kg of body weight) daily during estrus; five control mares received safflower oil on the same schedule. Mares were teased for estrus and samples of jugular blood were drawn daily through one full estrous cycle. Concentrations of FSH in plasma were measured by a newly developed radioimmunoassay based on anti-ovine FSH serum and radioiodinated equine FSH. Testosterone treatment during estrus had no effect on duration of estrus, diestrus or the total cycle. Concentrations of FSH in plasma during estrus were unaffected by testosterone treatment. However, FSH concentrations in testosterone-treated mares were elevated (P less than .05) compared with controls during mid-diestrus (d 6 through 11). The magnitude and timing of the LH peaks were unaffected by treatment, as was the day on which the first elevated progesterone concentration occurred. These data are consistent with a model of FSH secretion in which ovarian androgens cause an accumulation of FSH in the pituitary during estrus in preparation for the surges that occur in FSH secretion during diestrus.

Animals↗

Kinetics of the immune response of tumor-bearing hamsters to two simian virus 40 coded non-structural polypeptides present in simian virus 40 tumor cells.

The kinetics of the immune response of hamsters transplanted with virus-free SV40 tumor cells (TSV5) to two SV40-coded non-structural proteins of 94,000 daltons (T antigen) and 17,000 daltons (t antigen) was studied in order to determine if the variation in the immune reactivity of serum from tumor-bearing animals towards these proteins can be explained on the basis of differential immune response during various stages of tumor growth. The results demonstrate that individual animals vary in their capacity to respond immunologically to T and t antigens in SV40-transformed cells and that, further, the immune response to T and t antigens is influenced by the stage of tumor development.

Animals↗

Short-term mode of secretion of equine chorionic gonadotrop in and the effect of GNRH.

Five mature Quarterhorse mares were bled every 30 min for 25 h on day 50 of pregnancy to determine the short-term mode of secretion of equine chorionic gonadotropin (eCG). Three other mares with persistent endometrial cups after abortion were administered gonadotropin releasing hormone (GnRH; 1.0 mug/kg of body weight) and were bled immediately prior to and at 15, 30, 45, 60, 90, 120, 180 and 240 min after GnRH. Concentrations of eCG in plasma of pregnant mares were constant over the 24-h period; the variation of each mare's individual values was no greater (P>.05) than the predicted random variation of the radioimmunoassay. Administration of GnRH had no significant effect on eCG concentrations of mares with persistent endometrial cups over a 4-h period. These data are consistent with a model of eCG secretion in the pregnant mare in which there is little short-term regulation of secretion other than the factors which affect the number of healthy endometrial cup cells within the uterus.

Journal Article↗

Sexual behavior, seminal pH and accessory sex gland weights in geldings administered testosterone and(or) estradiol-17 beta.

Sixteen stallions were castrated and 30 days later assigned to one of four treatments: (1) testosterone propionate (175 microgram/kg body weight), (2) 17 beta-estradiol-3-benzoate (44 micrograms/kg body weight), (3) a combination of both steroids or, (4) vehicle only. These dosage were administered every other day for 18 days. The dosages were then doubled and continued for 20 days. Concentrations of testosterone and estradiol in serum decreased rapidly after castration and stabilized within about 6 hours. Mean concentrations of testosterone and estradiol maintained by the steroids were 1.4 and 90 pg/ml, respectively, during treatment at the lower dosage, and 2.6 and 186 pg/ml during treatment at the higher dosage. Libido and the ability to ejaculate were gradually lost after castration. Testosterone restored both aspects of sexual behavior within 2 weeks. Estradiol effectively restored libido at the higher dosage, but was less effective in restoring the ability to ejaculate. The pH of gel-free semen increased after castration and was subsequently decreased by treatment with testosterone or the combination of both steroids. Estradiol had no effect on seminal pH. Weights of the seminal vesicles, ampullae and prostate were greater in geldings treated with testosterone or with both steroids than in estradiol-treated or control geldings. Since estradiol alone was able to restore libido in geldings, it is possible that the maintenance of libido in intact stallions involves either estradiol secreted directly by the testes or estradiol arising from aromatization in peripheral tissues. Treatment with estradiol at either concentration, did not appear to affect the size or function of sex glands in geldings.

Animals↗

Cell-mediated immunity in Marek's disease virus-infected chickens genetically selected for high and low concentrations of plasma corticosterone.

Lines of chickens genetically selected for high (HPC)-and low-plasma corticosterone (LPC) titers were assessed for cell-mediated immunity during Marek's disease tumorigenesis. Lymphocyte transformation (using phytohemagglutinin and 2,4-dinitrofluorobenzene-bovine serum complex) and mitogen-induced cellular cytotoxicity were evaluated with peripheral blood leukocytes. Chickens from the LPC line showed a greater lymphocyte transformation response than those from the HPC line. All tumor-bearing chickens demonstrated a markedly suppressed blastogenic response. Although the blastogenic response was suppressed in those chickens infected with Marek's disease virus but not having gross tumors when compared with the steroid level, this response was greater than that of chickens with tumors and less than that of normal controls. In comparison with LPC-line chickens, HPC-line chickens demonstrated a decreased mitogen-induced cellular cytotoxicity. A decreased mitogen-induced cellular cytotoxicity was observed in both steroid lines concomitant with the onset and severity of tumors. The impaired cell-mediated response observed in the HPC line was associated with an increased tumor incidence and a greater mortality than that observed in the LPC line. Metyrapone, a chemical which blocks adrenal corticosterone synthesis, transiently enhanced mitogen-induced cellular cytotoxicity and initiated tumor regression in chickens debilitated with Marek's disease tumors.

Animals↗

Effects of age and frequency of ejaculation on sperm production and extragonadal sperm reserves in stallions.

Extragonadal reserves totalled 89 X 10(9) spermatozoa for 5--16-year-old sexually rested stallions and 60 X 10(9) for 2--4-year-olds. Regardless of age, the cauda epididymidis contained 62% of the total reserves and the vas deferens, including the ampulla, contained 7% of the total reserves of spermatozoa. The caput plus corpus epididymidis from 5--16-year-old stallions (N = 41) contained 14.9 X 10(9) spermatozoa per side as compared (P less than 0.01) to 8.5 X 10(9) for 2--4-year olds (N = 30). Frequency of ejaculation did not influence the number of spermatozoa found in caput plus corpus epididymidis. Across all ages, the number of spermatozoa potentially available for ejaculation from the cauda epididymidis and vas deferens on each side totalled 54 X 10(9). Collection of 5 successive ejaculates from sexually rested stallions removed 40--60% of the available spermatozoa while ejaculation every 2nd day reduced (P less than 0.05) the number of spermatozoa potentially available for ejaculation by 27%. Nevertheless, sufficient spermatozoa are produced daily (6.4 and 4.2 X 10(9) for 5--16-and 2--4-year-olds) to permit use of an average stallion once or twice daily, during spring and summer, providing sexual behaviour is adequate.

Aging↗